Searchable abstracts of presentations at key conferences in endocrinology

ea0083pno2 | Pituitary and Neuroendocrinology | EYES2022

Real-world use of intravenous hypertonic saline for hyponatraemia: a data-driven refinement of ESE guidelines

M. F. Arshad , A. Iqbal , J Weeks , A Munir , W Bennet

Background: The European Society of Endocrinology (ESE) published guidelines to standardise intravenous hypertonic saline (HTS) for severe symptomatic hyponatraemia in 2014. Two 150 mL boluses of 3.0% HTS are proposed, one after the other, to achieve an initial sodium rise of 5 mmol/l without waiting for an interval sodium result. ESE guidelines were adopted by our University Hospital in 2017. However, high rates of sodium overcorrection were observed, and the guidelines lacke...

ea0086cc10 | Featured Clinical Case Posters | SFEBES2022

Percutaneous pulmonary valve intervention in severe metastatic mid gut neuroendocrine tumour with carcinoid heart disease (hedinger syndrome): a case report

Karunanayaka Madushani , Bentham Jamie , Parry Helen , Munir Alia

Introduction: Carcinoid heart disease can occur in up to 20 % of patients with carcinoid syndrome. It is a regarded as a rare complication and associated with high morbidity and mortality as a sequela of vasoactive peptides resulting in plaque formation on the valve leaflets classically tricuspid and pulmonary valves and causing right heart failure. Definitive treatment is surgical valve replacement, but percutaneous valve management is an attractive alternative for those deem...

ea0086p46 | Endocrine Cancer and Late Effects | SFEBES2022

Neuroendocrine Tumour (NET) patient satisfaction in the COVID-19 recovery period: A patient survey from a European Neuroendocrine Tumour Centre of Excellence

Dabke Tanvi , Finnen John , Austin Helen , Munir Alia

Introduction: The COVID-19 pandemic has affected patient care and experience. We assessed the evolution of NET patient perceptions during and peri-pandemic via a bespoke patient satisfaction survey.Methods: In February 2022, questionnaires with a pre-paid return envelope were posted out to 87 randomly selected NET patients, treated between January and December 2021. This consisted of 29 questions covering: initial contact, physician care and support, ill...

ea0087p7 | Poster Presentations | UKINETS2022

Trans cather pulmonary valve replacement in carcinoid heart disease: a potential option in selected cases

Karunanayaka Madushani , Bentham Jamie , Parry Helen , Munir Alia

Introduction: Established guidelines recommend carefully selected patients with Carcinoid Heart Disease (CHD) may undergo surgical valve replacement as definitive management. Right sided heart valve involvement is classical, occurring as result of plaque deposition on valve leaflets as a consequence of vasoactive peptides secreted by the NET because of carcinoid syndrome. Tricuspid and Pulmonary valve involvement leads to right heart failure (RHF) increasing mortality and morb...

ea0062p09 | Poster Presentations | EU2019

Chronic diarrhoea - a rare endocrine cause

Pillai Sanesh , Munir Alia , Lorenz Eleanor , Wadsley John

Case history: A 59-year-old male presented to gastroenterology with a two years of high volume persistent watery diarrhoea. He gave a past medical history of poorly controlled, insulin treated diabetes mellitus present for 8 years. He reported abdominal pain and diarrhoea that persisted despite fasting. A colonoscopy with biopsy were reported as normal. Diarrhoea, malaise, fatigue and weight loss persisted.Investigations: Stool culture and faecal elastas...

ea0063p843 | Adrenal and Neuroendocrine Tumours 3 | ECE2019

Efficacy of somatostatin analogues in managing hypercalcaemia due to PTHrP in a well differentiated metastatic pancreatic neuroendocrine tumour and discussion of modern treatment options: A clinical case

Uchambally Manjima , Munir Alia , Wadsley Jonathan , Lorenz Eleanor

Pancreatic neuroendocrine tumours are rare with an incidence of 5 per million. Of these tumours, 75% maybe hormonally functioning. They carry a better prognosis than adenocarcinoma of the pancreas. Parathyroid Hormone related peptide hypersecretion in PNETs is uncommon and is solely associated with metastatic PNETs. 31 cases are reported of PTH-rPoma in the literature. Here we describe a novel case presenting with cough. A previously well 56-year-old female presented to the ac...

ea0044p119 | Diabetes and Cardiovascular | SFEBES2016

Freestyle Libre as a tool for management of hypoglycaemia in pregnancy complicated by type 1 diabetes mellitus

Gordon Valerie , Towse Karen , Madhuvrata Priya , Munir Alia

Introduction: Pregnancy in women with pre-existing Type 1 diabetes (T1DM) is known to carry a 3–5 times increased frequency of severe hypoglycaemia (SH) in the first compared to the third trimester. The main predictors are: pre-gestational SH, HbA1C <6.5%/48 mmol/mol, duration of diabetes and higher total daily insulin doses. Freestyle Libre or flash monitoring utilizes a 14 day tiny glucose sensor which is applied to the back of the arm and scanned with a reader, to ...

ea0038p103 | Clinical practice/governance and case reports | SFEBES2015

Splenunculi masquerading as neuroendocrine tumours

Walkinshaw Emma , Lorenz Eleanor , Blakeborough Tony , Munir Alia

Splenunculi or accessory spleens are congenital foci of normal splenic tissue that are separate from the main body of the spleen. They are common, with a prevalence of 16% on contrast-enhanced abdominal CT, and present in 10–30% of post mortem examinations. They are benign, and important to recognise to avoid unnecessary investigations and surgery for suspected malignancies.Splenunculi are usually asymptomatic and found incidentally. Typically on CT...

ea0038p159 | Neoplasia, cancer and late effects | SFEBES2015

Use of Sunitinib in refractory hypercalcaemia in pancreatic neuroendocrine tumours

Akbarian-Tefaghi Ladan , Wadsley Jonathan , Newell-Price John , Munir Alia

: The orally administered targeted therapies, Sunitinib and Everolimus lengthen progression free survival in pancreatic neuroendocrine tumours (pNETs). Choice of therapy has traditionally been on avoidance of deterioration in established co-morbidities. Sunitinib has been recognised to induce hypocalcaemia and the subsequent need for calcium supplementation has been reported. However, little has been documented about the utility and therapeutic significance of this effect....

ea0038p204 | Obesity, diabetes, metabolism and cardiovascular | SFEBES2015

Effect of vitamin D supplementation on cardiovascular risk factors and exercise performance in healthy subjects; a randomised placebo controlled pilot study

Munir Nimrah , Iniesta Raquel Revuelta , Al-Dujaili Emad A S

Background: Evidence suggests associations between vitamin D deficiency and cardiovascular risk factors, including hypertension and excessive cortisol levels. Also, vitamin D levels may be associated with exercise performance. Thus, we aimed to investigate the effects of vitamin D intake on cardiovascular risk factors, free urinary cortisol and exercise performance.Methods: A randomised placebo controlled single-blinded parallel trial was conducted in he...